Received: 11 December 2020
Accepted: 2 March 2021
First Online: 9 March 2021
: Ethical approval for Phase 2 of the study was granted by the School of Pharmacy Research Ethics Committee at Queen’s University Belfast (Reference number: 014PMY2019) and Phase 3 by the Faculty Research Ethics Committee at Queen’s University Belfast (Reference number: MHLS 20_50) respectively. Consent was obtained from all participants taking part in all consensus procedures.
: Not applicable.
: The authors declare that they have no competing interests.